UBS’s Allied Healthcare Products AHPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$1K Sell
223
-280
-56% -$1.2K ﹤0.01% 10204
2014
Q2
$2K Sell
503
-244
-33% -$1.11K ﹤0.01% 10090
2014
Q1
$3K Sell
747
-1,155
-61% -$5.47K ﹤0.01% 9884
2013
Q4
$9K Buy
1,902
+790
+71% +$3.65K ﹤0.01% 9119
2013
Q3
$5K Buy
1,112
+829
+293% +$4.21K ﹤0.01% 9449
2013
Q2
$2K Buy
+283
New +$1.51K ﹤0.01% 9855

Other funds holding AHPI

UBS's AHPI Position: Q3 2014 in Review

UBS reduced its Allied Healthcare Products (AHPI) stake by 56% in Q3 2014, selling an estimated $1.2K and leaving 223 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #10204.

UBS first reported a position in AHPI in Q2 2013 and has held it in 6 quarters since. The position peaked at $9K in Q4 2013. 17 funds tracked by Wall St. Rank hold AHPI as of Q3 2014.

  • UBS held 223 shares of Allied Healthcare Products worth $1K as of Q3 2014.
  • UBS sold 280 Allied Healthcare Products shares in Q3 2014, an estimated $1.2K.
  • Allied Healthcare Products made up ﹤0.01% of UBS's portfolio in Q3 2014, its #10204 holding.
  • UBS first reported a position in Allied Healthcare Products in Q2 2013 and has held it in 6 quarters since.
  • UBS's Allied Healthcare Products position peaked at $9K in Q4 2013.
  • 17 funds tracked by Wall St. Rank held Allied Healthcare Products as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.